Category: Danaher Corp.Syndicate content

ZMH proposes to mollify EU anti-trust regulators on pending, $13B acquisition Biomet | The week in medtech M&A

December 10, 2014 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Zimmer proposes divestitures for EU regulators in Biomet deal; China, South Korea OK Medtronic's $43B Covidien buy; BTG to buy PneumRx for up to $475m; BD prices $6.2B bond issue for CareFusion buy; Danaher's Leica division closes Devicor Medical buy

Zimmer proposes divestitures for EU regulators in Biomet deal

December 4, 2014 by Brad Perriello

Danaher's Leica division closes Devicor Medical buy

December 4, 2014 by Brad Perriello

Danaher's Leica Biosystems division closes its buyout of Devicor Medical Products, a developer of breast biopsy products, for an undisclosed amount.

Danaher's Leica division closes Devicor Medical buy

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Danaher's Leica division to buy Devicor Medical Products

October 28, 2014 by Val Kennedy

Danaher's Leica Biosystems division agrees to buy Devicor Medical Products, a developer of breast biopsy products.

Danaher's Leica division to buy Devicor Medical Products

Danaher (NYSE:DHR) said today that its Leica Biosystems division agreed to buy Devicor Medical Products, a developer of breast biopsy products.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Danaher becomes dental giant with $2.1B Nobel Biocare buy

September 15, 2014 by Arezu Sarvestani

The $2.14 billion acquisition of Nobel Biocare will turn Danaher into the largest dental implants provider in the world.

Danaher becomes dental giant with $2.1B Nobel Biocare buy

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Covidien acquires Reverse Medical | Medtech Wall Street news for the week of August 25, 2014

August 28, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Covidien snaps up Reverse Medical; Standard & Poor's maintains credit watch on Medtronic over Covidien buy; Allergan can't delay shareholder vote on hostile Valeant bid; Medtronic drops $200M on Dutch DBS firm Sapiens; Nobel Biocare's Q2 profits double as it fields buyout interest

Covidien snaps up Reverse Medical

August 22, 2014 by Brad Perriello

YYmeta

Nobel Biocare's Q2 profits double as it fields buyout interest

August 21, 2014 by Brad Perriello

Nobel Biocare doubles its 2nd-quarter profits as it reportedly fields interest – and at least 1 offer worth $2.3 billion – from potential acquirers.

Nobel Biocare's Q2 profits double as it fields buyout interest

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

JNJ looks to bolster "subscale" cardiovascular business | The week in medtech M&A

July 23, 2014 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Johnson & Johnson eyes acquisitions in cardiovascular, elsewhere; Abbott CEO defends inversions amid corporate exodus furor; Medtronic fights tax dodging rhetoric in Covidien merger; Could Medtronic-Covidien deal get caught in anti-inversion legislation?; Siemens sells clinical microbiology biz to Beckman Coulter

Johnson & Johnson eyes acquisitions in cardiovascular, elsewhere

July 16, 2014 by Brad Perriello

YYmeta
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp